table of content
1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Viral Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Market by Application
1.3.1 Global Viral Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Viral Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Viral Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Viral Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Viral Vaccines Sales by Region
2.4.1 Global Viral Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Viral Vaccines by Region (2023-2028)
2.5 Global Viral Vaccines Revenue by Region
2.5.1 Global Viral Vaccines Revenue by Region (2017-2022)
2.5.2 Global Viral Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Viral Vaccines Sales by Manufacturers
3.1.1 Global Top Viral Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Viral Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viral Vaccines in 2021
3.2 Global Viral Vaccines Revenue by Manufacturers
3.2.1 Global Viral Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Viral Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2021
3.3 Global Viral Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Viral Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Viral Vaccines Sales by Type
4.1.1 Global Viral Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Viral Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Viral Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Viral Vaccines Revenue by Type
4.2.1 Global Viral Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Viral Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Viral Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Viral Vaccines Price by Type
4.3.1 Global Viral Vaccines Price by Type (2017-2022)
4.3.2 Global Viral Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Viral Vaccines Sales by Application
5.1.1 Global Viral Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Viral Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Viral Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Viral Vaccines Revenue by Application
5.2.1 Global Viral Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Viral Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Viral Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Viral Vaccines Price by Application
5.3.1 Global Viral Vaccines Price by Application (2017-2022)
5.3.2 Global Viral Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Viral Vaccines Market Size by Type
6.1.1 North America Viral Vaccines Sales by Type (2017-2028)
6.1.2 North America Viral Vaccines Revenue by Type (2017-2028)
6.2 North America Viral Vaccines Market Size by Application
6.2.1 North America Viral Vaccines Sales by Application (2017-2028)
6.2.2 North America Viral Vaccines Revenue by Application (2017-2028)
6.3 North America Viral Vaccines Market Size by Country
6.3.1 North America Viral Vaccines Sales by Country (2017-2028)
6.3.2 North America Viral Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Viral Vaccines Market Size by Type
7.1.1 Europe Viral Vaccines Sales by Type (2017-2028)
7.1.2 Europe Viral Vaccines Revenue by Type (2017-2028)
7.2 Europe Viral Vaccines Market Size by Application
7.2.1 Europe Viral Vaccines Sales by Application (2017-2028)
7.2.2 Europe Viral Vaccines Revenue by Application (2017-2028)
7.3 Europe Viral Vaccines Market Size by Country
7.3.1 Europe Viral Vaccines Sales by Country (2017-2028)
7.3.2 Europe Viral Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Viral Vaccines Market Size by Type
8.1.1 Asia Pacific Viral Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Viral Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Viral Vaccines Market Size by Application
8.2.1 Asia Pacific Viral Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Viral Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Viral Vaccines Market Size by Region
8.3.1 Asia Pacific Viral Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Viral Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Viral Vaccines Market Size by Type
9.1.1 Latin America Viral Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Viral Vaccines Revenue by Type (2017-2028)
9.2 Latin America Viral Vaccines Market Size by Application
9.2.1 Latin America Viral Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Viral Vaccines Revenue by Application (2017-2028)
9.3 Latin America Viral Vaccines Market Size by Country
9.3.1 Latin America Viral Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Viral Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viral Vaccines Market Size by Type
10.1.1 Middle East and Africa Viral Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Viral Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Viral Vaccines Market Size by Application
10.2.1 Middle East and Africa Viral Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Viral Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Viral Vaccines Market Size by Country
10.3.1 Middle East and Africa Viral Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Viral Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Zoetis
11.7.1 Zoetis Corporation Information
11.7.2 Zoetis Overview
11.7.3 Zoetis Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Zoetis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zoetis Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Johnson
11.9.1 Johnson Corporation Information
11.9.2 Johnson Overview
11.9.3 Johnson Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson Recent Developments
11.10 CSL
11.10.1 CSL Corporation Information
11.10.2 CSL Overview
11.10.3 CSL Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CSL Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Viral Vaccines Industry Chain Analysis
12.2 Viral Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viral Vaccines Production Mode & Process
12.4 Viral Vaccines Sales and Marketing
12.4.1 Viral Vaccines Sales Channels
12.4.2 Viral Vaccines Distributors
12.5 Viral Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Viral Vaccines Industry Trends
13.2 Viral Vaccines Market Drivers
13.3 Viral Vaccines Market Challenges
13.4 Viral Vaccines Market Restraints
14 Key Findings in The Global Viral Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
